<DOC>
	<DOCNO>NCT01967186</DOCNO>
	<brief_summary>Islet transplantation promise treatment type 1 diabetes select case . Results however hamper relatively low number islet survive transplantation liver , currently site transplantation . In present study compare new transplantation site ( intramuscular arm ) golden standard ( liver ) patient undergo kidney transplantation donor . In half intramuscular transplant patient , islet mix mesenchymal stemcells recipient , possibly , improve immunological aspect transplantation .</brief_summary>
	<brief_title>Intraportal Intramuscular Site Islets Simultaneous Islet Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Male female patient age 18 65 year age . Ability provide write informed consent . Mentally stable able comply procedure study protocol . Clinical history compatible type 1 diabetes onset disease &lt; 40 year age insulindependence &gt; 5 year time enrolment . Absence stimulate Cpeptide &lt; 0.1 nmol/L response MMTT . All subject must receive adequate medical treatment diabetes guidance experienced diabetologist . All subject must renal failure eligible renal transplantation accord local criterion . Patients prior organ transplant Patients qualify local simultaneous pancreaskidney transplantation program prefer option Patients body mass index BMI &gt; 28 . Insulin requirement &gt; 1 Unit/kg/day . If patient peritoneal dialysis limit set extra carbohydrate dialysis fluid account . Consistently abnormal liver function test ( &gt; 1.5 x upper limit normal two consecutive measurement &gt; 2 week apart ) Unstable diabetic retinopathy Hypercoagulability disorder coagulopathy International normalized ratio ( INR ) &gt; 1.5 Any history malignancy except completely resect squamous basal cell carcinoma skin Patients unstable cardiovascular status Patients active infection , unless treatment judge necessary investigator Patients serological evidence infection HIV , hepatitis B ( patient serology consistent previous vaccination history vaccination acceptable ) hepatitis C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Type 1 diabetes</keyword>
	<keyword>islet</keyword>
	<keyword>transplantation</keyword>
	<keyword>nephropathy</keyword>
	<keyword>intramuscular</keyword>
</DOC>